Lars John Anders Månsson

Chief Executive Officer, Iconovo AB

Bispgatan 715 active roles

Lars John Anders Månsson holds 5 active roles in Swedish companies registered in Bolagsverket, including Chief Executive Officer at Iconovo AB since 2025 and Chief Executive Officer at Iconovo Pharma AB since 2025. 6 earlier roles have ended, the most recent in 2026.

Overview

Active roles

directorships & management

Past roles

historical positions

Dissolved companies

Career timeline

2025 – now
Chief Executive Officer, Iconovo AB
2025 – now
Chief Executive Officer, Iconovo Pharma AB
2024 – 2026
Board of Directors, Sturgeon Consult AB
2024 – 2025
Chief Executive Officer, Phase Holographic Imaging PHI AB
2022 – now
Chief Executive Officer, Anders Månsson Business Development AB
2022 – now
Board of Directors, Immetric AB
2022 – 2023
Chief Executive Officer, LIDDS AB
2022 – 2023
Board of Directors, LIDDS Pharma AB
2021 – 2022
Board of Directors, Amniotics AB (publ)
2020 – now
Board of Directors, EQL Pharma AB
2020 – 2022
Chief Executive Officer, Chosa Oncology AB

Personal details

Address

Bispgatan 71

Companies & roles

Active roles

5 positions

Company	Role	Period	Ownership	Status
EQL Pharma AB CVR 5567133425	BoardBoard of Directors	Since 2020	—	Active
Iconovo AB CVR 5569380156	ManagementChief Executive Officer	Since 2025	—	Active
Anders Månsson Business Development AB CVR 5591394878	ManagementChief Executive Officer	Since 2022	—	Active
Immetric AB CVR 5593317299	BoardBoard of Directors	Since 2022	—	Active
Iconovo Pharma AB CVR 5593430225	ManagementChief Executive Officer	Since 2025	—	Active

Historical roles

6 positions

Company	Role	Period	Ownership	Status
Phase Holographic Imaging PHI AB CVR 5565427811	ManagementChief Executive Officer	2024 – 2025	—	Active
LIDDS AB CVR 5565802856	ManagementChief Executive Officer	2022 – 2023	—	Active
Amniotics AB (publ) CVR 5590246558	BoardBoard of Directors	2021 – 2022	—	Dissolved
Chosa Oncology AB CVR 5590372271	ManagementChief Executive Officer	2020 – 2022	—	Active
LIDDS Pharma AB CVR 5591489421	BoardBoard of Directors	2022 – 2023	—	Active
Sturgeon Consult AB CVR 5594355033	BoardBoard of Directors	2024 – 2026	—	Active

2 companies dissolved after bankruptcy or enforced closure where the role ended within the last 5 years

Phase Holographic Imaging PHI AB

CVR 5565427811 · Under bankruptcy · role ended 2025

Role: Chief Executive Officer

LIDDS AB

CVR 5565802856 · Under bankruptcy · role ended 2023

Role: Chief Executive Officer

Network

Company network

Active roles

Lars John Anders Månsson

EQL Pharma AB

Board of Directors

Iconovo AB

Chief Executive Officer

Anders Månsson Business Development AB

Chief Executive Officer

Immetric AB

Board of Directors

Iconovo Pharma AB

Chief Executive Officer

Past companies

Phase Holographic Imaging PHI AB LIDDS AB Amniotics AB (publ)Chosa Oncology AB LIDDS Pharma AB Sturgeon Consult AB

Co-directors & shared companies

Person	Role	Shared companies	Profile
MS Maria Sofia Ekelund	Chief Auditor	2companies	View profile
LC Lars Christer Fredrik Fåhraeus	Chairman	1company	View profile
AN Axel Nils-Ingvar Schörling	Chief Executive Officer	1company	View profile
PO Per Olof Svangren	Board of Directors	1company	View profile
NS Nikunj Shah	Board of Directors	1company	View profile

Is this you? About the data on this page

This profile is compiled automatically from Bolagsverket / SCB, the official business register in Sweden. Riskpilot is operated by Risika A/S, which is the data controller for this page. We don't add private information — only the roles and details the register itself publishes.

Because this is public register data, it can't be erased — corrections to the underlying record are made with the register, and we pick them up once they're published. You do have the right to object to how your details are shown here, and we can de-index this profile so it no longer appears in search engines such as Google.

To make a request, email privacy@risika.com with a link to this page. We respond within 30 days. Read more in our privacy policy.